2023
Enhanced Identification of Hispanic Ethnicity Using Clinical Data
Ochoa-Allemant P, Tate J, Williams E, Gordon K, Marconi V, Bensley K, Rentsch C, Wang K, Taddei T, Justice A, Cohorts F. Enhanced Identification of Hispanic Ethnicity Using Clinical Data. Medical Care 2023, 61: 200-205. PMID: 36893404, PMCID: PMC10114212, DOI: 10.1097/mlr.0000000000001824.Peer-Reviewed Original ResearchConceptsBurden of diseaseHispanic patientsCountry of birthClinical dataHispanic ethnicityNon-Hispanic white patientsSex-adjusted prevalenceChronic liver diseaseHuman immunodeficiency virusDemographic characteristicsElectronic health record dataHealth careHealth record dataPrevalence of conditionsUS health care systemMedicare administrative dataHealth care systemWhite patientsLiver diseaseImmunodeficiency virusSelf-reported ethnicityHigh prevalenceGastric cancerHepatocellular carcinomaVeteran population
2022
Differences in COVID-19 testing and adverse outcomes by race, ethnicity, sex, and health system setting in a large diverse US cohort
Jefferson C, Watson E, Certa J, Gordon K, Park L, D’Souza G, Benning L, Abraham A, Agil D, Napravnik S, Silverberg M, Leyden W, Skarbinski J, Williams C, Althoff K, Horberg M, Team O. Differences in COVID-19 testing and adverse outcomes by race, ethnicity, sex, and health system setting in a large diverse US cohort. PLOS ONE 2022, 17: e0276742. PMID: 36417366, PMCID: PMC9683575, DOI: 10.1371/journal.pone.0276742.Peer-Reviewed Original ResearchConceptsSARS-CoV-2 testingRace/ethnicityRelative risk ratiosAdverse outcomesCOVID-19 testingHealth system typesWhite patientsBlack patientsUS cohortCOVID-19-related hospitalizationAsian/Pacific Islander patientsDiverse US cohortPacific Islander patientsLow positivity rateCOVID-19 pandemicEvidence of disparitiesElectronic health recordsCohort CollaborationHispanic patientsPatient reportingPrimary exposureRisk ratioRisk factorsPositivity rateHigh burden
2016
Comparative Effectiveness of Diabetic Oral Medications Among HIV-Infected and HIV-Uninfected Veterans
Han JH, Gordon K, Womack JA, Gibert CL, Leaf DA, Rimland D, Rodriguez-Barradas MC, Bisson GP. Comparative Effectiveness of Diabetic Oral Medications Among HIV-Infected and HIV-Uninfected Veterans. Diabetes Care 2016, 40: 218-225. PMID: 27634393, PMCID: PMC5250696, DOI: 10.2337/dc16-0718.Peer-Reviewed Original ResearchMeSH KeywordsAdultBlack or African AmericanBlood GlucoseBody Mass IndexComparative Effectiveness ResearchDiabetes Mellitus, Type 2FemaleFollow-Up StudiesGlycated HemoglobinHispanic or LatinoHIV InfectionsHumansHypoglycemic AgentsLongitudinal StudiesMaleMetforminMiddle AgedSulfonylurea CompoundsThiazolidinedionesVeteransWhite PeopleConceptsType 2 diabetesDiabetic medicationsHIV infectionHispanic patientsPoor responseGlycemic responseOral diabetic medicationsLongitudinal cohort studyBaseline HbAGlycemic effectivenessHIV-InfectedUninfected veteransMedication initiationCohort studyOral medicationsWhite patientsPotential confoundersClinical covariatesMedicationsHIVPatientsType 2Comparative effectivenessPropensity scoreDiabetes